NEXT BIG INNOVATION LABS PRIVATE LIMITED

In their own words

Next Big Innovation Labs - www.nextbiglab.com Next Big Innovation Labs is a Deep Tech Lifesciences platform, focused on developing 3D Bioprinting Technology and Products for R&D, Industrial and Clinical Applications. Next Big Innovation Labs (NBIL) is working towards one day eliminating the need to have organ transplant wait lists. NBIL's long term goal is to empower the scientific community with their proprietary technology and expertise, to one day being able to create patient specific transplantable organs in the lab. NBIL is a proudly born in India company, with a vision to create innovative healthcare products for the world market. NBIL is currently working towards creating 3D Bioprinted skin tissues, using their proprietary 3D Bioprinting technology. NBIL's products are aimed at eliminating the need for animal testing and providing researchers across cosmetic, FMCG and pharmaceutical companies; access to viable alternatives to human skin. NBIL’s Bioprinting platform provides us the opportunity to work on emerging applications across industries. 3D Bioprinting is set to be the base technology towards creating products that will enable more efficient and faster drug testing, enable the transition from animal testing and to empower researchers and clinicians to develop personalised therapies and treatments. NBIL with its platform, expertise, collaborations and products; will enable the industry to leapfrog in this regard. The company is currently funded by equity free grants from Government of Karnataka, under their Idea2PoC program ; TATA Trusts - Lockheed Martin - Department of Science & Technology, India Innovation Growth Program 2.0 and Department of Biotechnology's BIG grant and Merck Group, Germany.

Written by the company on its public Startup India profile. Not verified by us.